Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.3.23 (
GAS
)
957
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PMP22
(peripheral myelin protein 22), also known as
GAS
3 (growth-arrest-specific protein 3), is a disease-linked tetraspan glycoprotein of peripheral nerve myelin and constituent of intercellular junctions in epithelia. To date, our knowledge of the post-translational modification of
PMP22
is limited. Using the CSS-Palm 2.0 software we predicted that C85 (cysteine 85), a highly conserved amino acid located between the second and third transmembrane domains, is a potential site for palmitoylation. To test this, we mutated C85S (C85 to serine) and established stable cells lines expressing the WT (wild-type) or the C85S-
PMP22
. In Schwann and MDCK (Madin-Darby canine kidney) cells mutating C85 blocked the palmitoylation of
PMP22
, which we monitored using 17-ODYA (17-octadecynoic acid). While palmitoylation was not necessary for processing the newly synthesized
PMP22
through the secretory pathway, overexpression of C85S-
PMP22
led to pronounced cell spreading and uneven monolayer thinning. To further investigate the functional significance of palmitoylated
PMP22
, we evaluated MDCK cell migration in a wound-healing assay. While WT-
PMP22
expressing cells were resistant to migration, C85S cells displayed lamellipodial protrusions and migrated at a similar rate to vector control. These findings indicate that palmitoylation of
PMP22
at C85 is critical for the role of the protein in modulating epithelial cell shape and motility.
...
PMID:The palmitoylation state of PMP22 modulates epithelial cell morphology and migration. 2312 55